NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.55
USD |
NASDAQ |
Apr 04, 16:00
NGM Biopharmaceuticals Enterprise Value: -15.65M for April 5, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Catalent Inc (DELISTED) | -- |
| AIM ImmunoTech, Inc. | 3.782M |
| Perspective Therapeutics, Inc. | 23.94M |
| Protalix Biotherapeutics, Inc. | 144.47M |
| Armata Pharmaceuticals, Inc. | 370.01M |
Enterprise Value Related Metrics
| Profit Margin (Quarterly) | -16.77K% |
| Earnings Yield | -112.3% |
| Normalized Earnings Yield | -112.34 |